Skip to main navigation Skip to search Skip to main content

Luteinizing hormone-releasing hormone analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor-positive breast cancer

Research output: Contribution to journalArticle

Original languageEnglish
JournalExpert Opinion on Pharmacotherapy
Publication statusPublished - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this